Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study Post date November 15, 2022 ← Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study → Categorisation of myopia progression by change in refractive error and axial elongation and their impact on benefit of myopia control using orthokeratology.
